Online citations, reference lists, and bibliographies.
← Back to Search

Neurodegenerative Dementia And Parkinsonism

A. Gabelle, F. Portet, C. Berr, J. Touchon
Published 2010 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BackgroundDementia and Parkinsonism are two major neurodegenerative disorders. Accurate diagnosis can be difficult when patients have both syndromes because of a wide range of etiologies.ObjectivesTo improve clinical diagnosis, we propose a disease classification based on the pathological proteins which are involved in the neuropathological disease process.DesignFour neuropathological classes are proposed based on four major proteins, tau, Aβ, α-synuclein and TDP43: 1/ Tauopathy and amyloidopathy with possible Parkinsonism, 2/ Tauopathy with predominant Parkinsonism, 3/ Synucleinopathies with cognitive impairment/dementia and 4/ The TAR DNA binding protein 43 (TDP-43). This classification raises certain questions in clinical practice due to intriguing overlaps between clinical presentations despite the same pathological protein being involved.ConclusionThe development of molecular and pathological protein research in neurodegenerative disorders can help classify the clinical association of dementia and Parkinsonism and improve therapeutic strategies against proteins involved in the degenerative process.
This paper references
10.1136/jnnp.54.1.34
Extrapyramidal features in advanced Down's syndrome: clinical evaluation and family history.
P. Vieregge (1991)
10.1093/HMG/DDL241
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.
J. Gass (2006)
10.1093/BRAIN/AWL268
Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study.
B. Boeve (2006)
10.1136/jnnp.64.2.184
Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination
G. Wenning (1998)
10.1177/153331750101600512
Extrapyramidal symptoms and signs in Alzheimer's disease: Pravalence and correlation with the first symptom
M. Tsolaki (2001)
10.1016/j.neurobiolaging.2007.05.009
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy
B. Borroni (2009)
10.1002/mds.20527
A systematic review of prevalence studies of dementia in Parkinson's disease
D. Aarsland (2005)
10.3233/JAD-2008-14404
Phosphorylated tau: toxic, protective, or none of the above.
R. Castellani (2008)
10.1159/000101848
Frontotemporal Dementia with Tau Pathology
L. Gasparini (2007)
10.1176/AJP.151.3.390
A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.
R. Stern (1994)
10.1136/jnnp.74.6.720
Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older
T. Rahkonen (2003)
10.1086/420978
Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance.
E. Buratti (2004)
10.1042/BST0351219
Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction.
M. Rowan (2007)
10.1097/nen.0b013e3181587d64
Protein Aggregation Mechanisms in Synucleinopathies: Commonalities and Differences
K. Beyer (2007)
10.1212/WNL.55.4.539
Motor impairment in PD
G. Levy (2000)
10.4161/auto.5604
Ubiquitination of α-synuclein and autophagy in Parkinson's disease
S. Engelender (2008)
10.1212/WNL.54.4.818
Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions
A. Kertesz (2000)
10.1083/jcb.200712039
Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival
P. van Damme (2008)
[Fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17): clinical criteria].
Z. Wszolek (2003)
10.1007/s00109-003-0474-3
Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis
Z. He (2003)
10.1126/SCIENCE.1072994
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
J. Hardy (2002)
10.1007/s00234-007-0265-6
Imaging of corticobasal degeneration syndrome
M. Koyama (2007)
10.1093/BRAIN/AWL267
Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia.
J. Snowden (2006)
10.1016/j.neurobiolaging.2007.08.022
Prominent phenotypic variability associated with mutations in Progranulin
B. Kelley (2009)
10.1002/ana.20963
HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin‐positive, tau‐negative inclusions caused by a missense mutation in the signal peptide of progranulin
O. Mukherjee (2006)
10.1186/1742-2094-4-7
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Z. Ahmed (2007)
10.1080/13607860601086439
Do extrapyramidal features in Alzheimer patients treated with acetylcholinesterase inhibitors predict disease progression?
H. Brodaty (2007)
10.1212/01.WNL.0000165977.38272.15
“Applause sign” helps to discriminate PSP from FTD and PD
B. Dubois (2005)
10.1016/S1474-4422(07)70221-1
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative
R. Rademakers (2007)
10.1002/mds.21337
Asymmetrical alien hands in corticobasal degeneration
D. B. Fitzgerald (2007)
10.1136/jnnp.57.12.1503
Extrapyramidalism in Alzheimer's disease: prevalence, psychiatric, and neuropsychological correlates.
M. Merello (1994)
10.1074/jbc.M710418200
alpha-Synuclein aggregates interfere with Parkin solubility and distribution: role in the pathogenesis of Parkinson disease.
Kohichi Kawahara (2008)
10.3233/JAD-2008-14413
The last tangle of tau.
Huiping Ding (2008)
10.1093/BRAIN/AWM111
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.
C. Williams-Gray (2007)
10.1111/j.1471-4159.2007.04968.x
Progranulin: normal function and role in neurodegeneration
Jason L. Eriksen (2008)
10.1001/ARCHNEUR.64.3.371
Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations.
J. Whitwell (2007)
10.1172/JCI32806
Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy.
M. Martinez-Vicente (2008)
10.1212/01.wnl.0000249307.59950.f8
Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI
C. Blain (2006)
10.1001/archneur.65.6.796
White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia.
B. Borroni (2008)
10.1016/j.neurobiolaging.2006.09.019
Voxel-based morphometry in autopsy proven PSP and CBD
K. Josephs (2008)
10.1002/HUMU.9484
Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia
J. Van der Zee (2007)
10.1093/BRAIN/AWL271
The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene.
I. Mackenzie (2006)
10.1093/brain/awn195
Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
G. Rizzo (2008)
10.1002/mds.22090
Applause sign in parkinsonian disorders and Huntington's disease
Laura J C Wu (2008)
10.1093/brain/awn012
Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.
I. Le Ber (2008)
10.1007/s00415-006-0234-8
The effect of age of onset of PD on risk of dementia
D. Aarsland (2006)
10.1038/nature05016
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
M. Baker (2006)
10.1002/ANA.410020509
The ocular motor defects in progressive supranuclear palsy
B. Troost (1977)
10.1002/MDS.870040402
Eyelid movement abnormalities in progressive supranuclear palsy
Lawrence I. Golbe (1989)
10.1002/mds.1131
Frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP‐17): PPND family. A longitudinal videotape demonstration
Zbigniew K. Wszolek (2005)
10.1212/01.wnl.0000242630.52203.8f
Clinical phenotype of Parkinson disease dementia
J. Galvin (2006)
10.1002/HUMU.20520
Progranulin null mutations in both sporadic and familial frontotemporal dementia
I. Le Ber (2007)
10.1038/35086072
Alzheimer's disease and Aβ toxicity: from top to bottom
David H. Small (2001)
10.1097/00005072-199409000-00003
Alzheimer's Disease: A Central Role for Amyloid
D. Selkoe (1994)
10.1097/nen.0b013e31803020cf
Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With Progranulin Gene (PGRN) Mutations
K. Josephs (2007)
10.1111/j.1471-4159.2006.04146.x
Alpha‐synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells
Roya Tehranian (2006)
10.1093/brain/awm320
A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.
J. Beck (2008)
10.1126/SCIENCE.1134108
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
M. Neumann (2006)
10.1001/ARCHNEUR.64.1.43
Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families.
M. Mesulam (2007)
10.1002/9781444341256.CH14
Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17): PPND family. A longitudinal videotape demonstration.
Z. Wszolek (2001)
10.1016/S0002-9440(10)65721-5
Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau.
M. Spillantini (1998)
10.1212/01.wnl.0000256715.13907.d3
DLB and PDD boundary issues
C. Lippa (2007)
10.1093/BRAIN/124.10.1948
Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22.
S. Rosso (2001)
10.1212/01.WNL.0000162054.15428.E9
Motor signs predict poor outcomes in Alzheimer disease
N. Scarmeas (2005)
10.1093/nar/gki897
Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene
Pablo Arrisi Mercado (2005)
10.1001/ARCHNEUR.60.3.387
Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.
D. Aarsland (2003)
10.1242/jcs.02481
α-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells
X. Peng (2005)
10.1016/j.neurobiolaging.2006.10.028
A novel deletion in progranulin gene is associated with FTDP-17 and CBS
L. Benussi (2008)
10.1002/ANA.410410606
Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
N. Foster (1997)
10.1002/mds.21507
Clinical diagnostic criteria for dementia associated with Parkinson's disease
M. Emre (2007)
10.1212/01.WNL.0000138440.39918.0C
Motor signs during the course of Alzheimer disease
N. Scarmeas (2004)
10.1136/jnnp.2003.027367
Abnormalities of optokinetic nystagmus in progressive supranuclear palsy
S. Garbutt (2004)
10.29819/ANT.200703.0003
Clinical, imaging and electrophysiological studies of corticobasal degeneration.
Kai-Ju Huang (2007)
10.1212/01.wnl.0000205132.62517.09
New and reliable MRI diagnosis for progressive supranuclear palsy.
H. Oba (2005)
10.1016/S0969-9961(02)00011-6
Tau and neurofilaments in a family with frontotemporal dementia unlinked to chromosome 17q21–22
A. Savioz (2003)
10.1016/S0531-5565(02)00141-9
Tau aggregation in the hippocampal formation: an ageing or a pathological process?
A. Delacourte (2002)
10.1093/BRAIN/AWL276
Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome.
M. Masellis (2006)
10.1038/31508
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
M. Hutton (1998)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar